Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection.

Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, D'Angelica MI, Balduzzi A, Bassi C, Björnsson B, Boggi U, Callery MP, Del Chiaro M, Coimbra FJ, Conrad C, Cook A, Coppola A, Dervenis C, Dokmak S, Edil BH, Edwin B, Giulianotti PC, Han HS, Hansen PD, van der Heijde N, van Hilst J, Hester CA, Hogg ME, Jarufe N, Jeyarajah DR, Keck T, Kim SC, Khatkov IE, Kokudo N, Kooby DA, Korrel M, de Leon FJ, Lluis N, Lof S, Machado MA, Demartines N, Martinie JB, Merchant NB, Molenaar IQ, Moravek C, Mou YP, Nakamura M, Nealon WH, Palanivelu C, Pessaux P, Pitt HA, Polanco PM, Primrose JN, Rawashdeh A, Sanford DE, Senthilnathan P, Shrikhande SV, Stauffer JA, Takaori K, Talamonti MS, Tang CN, Vollmer CM, Wakabayashi G, Walsh RM, Wang SE, Zinner MJ, Wolfgang CL, Zureikat AH, Zwart MJ, Conlon KC, Kendrick ML, Zeh HJ, Hilal MA, Besselink MG; International Study Group on Minimally Invasive Pancreas Surgery (I-MIPS).

Ann Surg. 2019 Sep 16. doi: 10.1097/SLA.0000000000003590. [Epub ahead of print]

PMID:
31567509
2.

Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade.

Rauch DA, Conlon KC, Janakiram M, Brammer JE, Harding JC, Ye BH, Zang X, Ren X, Olson S, Cheng X, Miljkovic MD, Sundaramoorthi H, Joseph A, Skidmore ZL, Griffith O, Griffith M, Waldmann TA, Ratner L.

Blood. 2019 Oct 24;134(17):1406-1414. doi: 10.1182/blood.2019002038.

PMID:
31467059
3.

Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.

Griffin OM, Duggan SN, Ryan R, McDermott R, Geoghegan J, Conlon KC.

Pancreatology. 2019 Sep;19(6):850-857. doi: 10.1016/j.pan.2019.07.039. Epub 2019 Jul 24.

PMID:
31362865
4.

Clinical Classification and Severity Scoring Systems in Chronic Pancreatitis: A Systematic Review.

Rahman A, O'Connor DB, Gather F, Koscic S, Gilgan J, Mockler D, Bashir Y, Memba R, Duggan SN, Conlon KC.

Dig Surg. 2019 Jul 3:1-11. doi: 10.1159/000501429. [Epub ahead of print] Review.

5.

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

Cooley S, He F, Bachanova V, Vercellotti GM, DeFor TE, Curtsinger JM, Robertson P, Grzywacz B, Conlon KC, Waldmann TA, McKenna DH, Blazar BR, Weisdorf DJ, Miller JS.

Blood Adv. 2019 Jul 9;3(13):1970-1980. doi: 10.1182/bloodadvances.2018028332.

6.

IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion.

Conlon KC, Potter EL, Pittaluga S, Lee CR, Miljkovic MD, Fleisher TA, Dubois S, Bryant BR, Petrus M, Perera LP, Hsu J, Figg WD, Peer CJ, Shih JH, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA.

Clin Cancer Res. 2019 Aug 15;25(16):4945-4954. doi: 10.1158/1078-0432.CCR-18-3468. Epub 2019 May 29.

7.

Single-stage approach for the management of choledocolithiasis with concomitant cholelithiasis. Implementation of a protocol in a secondary hospital.

Memba R, González S, Coronado D, González V, Mata F, Rodríguez JA, Mühlenberg C, Sala J, Ribas R, Pueyo E, Mata A, O'Connor DB, Conlon KC, Jorba R.

Surgeon. 2019 Dec;17(6):351-359. doi: 10.1016/j.surge.2018.12.001. Epub 2019 Jan 29.

PMID:
30704859
8.

Management of Pancreatic Cystic Lesions.

Perri G, Marchegiani G, Frigerio I, Dervenis CG, Conlon KC, Bassi C, Salvia R.

Dig Surg. 2019 Jan 11:1-9. doi: 10.1159/000496509. [Epub ahead of print] Review.

9.

A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts.

Coleman O, Henry M, O'Neill F, Roche S, Swan N, Boyle L, Murphy J, Meiller J, Conlon NT, Geoghegan J, Conlon KC, Lynch V, Straubinger NL, Straubinger RM, McVey G, Moriarty M, Meleady P, Clynes M.

Proteomes. 2018 Nov 6;6(4). pii: E45. doi: 10.3390/proteomes6040045.

10.

IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability.

Wang TT, Yang J, Zhang Y, Zhang M, Dubois S, Conlon KC, Tagaya Y, Hamele CE, Dighe S, Olson TL, Feith DJ, Azimi N, Waldmann TA, Loughran TP Jr.

Leukemia. 2019 May;33(5):1243-1255. doi: 10.1038/s41375-018-0290-y. Epub 2018 Oct 23.

11.

Cytokines in the Treatment of Cancer.

Conlon KC, Miljkovic MD, Waldmann TA.

J Interferon Cytokine Res. 2019 Jan;39(1):6-21. doi: 10.1089/jir.2018.0019. Epub 2018 Jun 11.

PMID:
29889594
12.

Systematic review and meta-analysis on the effect of obesity on recurrence after laparoscopic anti-reflux surgery.

Bashir Y, Chonchubhair HN, Duggan SN, Memba R, Ain QU, Murphy A, McMahon J, Ridgway PF, Conlon KC.

Surgeon. 2019 Apr;17(2):107-118. doi: 10.1016/j.surge.2018.05.001. Epub 2018 Jun 7.

PMID:
29887315
13.

Trends in the Use of Laparoscopic Versus Open Paediatric Appendicectomy: A Regional 12-Year Study and a National Survey.

Bhatt NR, Dunne E, Faraz M, Gillis AE, Conlon KC, Paran S, Ridgway PF.

World J Surg. 2018 Nov;42(11):3792-3802. doi: 10.1007/s00268-018-4688-5.

PMID:
29855686
14.

Sarcopenia-A New Frontier in the Management Care of Patients With Borderline Resectable Pancreatic Cancer.

Griffin O, Conlon KC.

JAMA Surg. 2018 Sep 1;153(9):816. doi: 10.1001/jamasurg.2018.1006. No abstract available.

PMID:
29801035
15.

The Role of Staging Laparoscopy in Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Ta R, O'Connor DB, Sulistijo A, Chung B, Conlon KC.

Dig Surg. 2019;36(3):251-260. doi: 10.1159/000488372. Epub 2018 Apr 12.

PMID:
29649825
16.

The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI).

Ní Chonchubhair HM, Bashir Y, Dobson M, Ryan BM, Duggan SN, Conlon KC.

Pancreatology. 2018 Jun;18(4):379-385. doi: 10.1016/j.pan.2018.02.010. Epub 2018 Feb 24.

PMID:
29502987
17.

The Practical Management of Chronic Pancreatitis: A Multidisciplinary Symposium Held at the Annual Meeting of the Pancreatic Society of Great Britain and Ireland, Manchester 2016.

Jegatheeswaran S, Puleston JM, Duggan S, Hart A, Conlon KC, Siriwardena AK.

Dig Surg. 2019;36(1):41-45. doi: 10.1159/000486399. Epub 2018 Jan 16.

PMID:
29339657
18.

A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors.

Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HEK, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC, Cheever MA, Streicher H, Creekmore SP, Waldmann TA, Conlon KC.

Clin Cancer Res. 2018 Apr 1;24(7):1525-1535. doi: 10.1158/1078-0432.CCR-17-2451. Epub 2017 Dec 4.

19.

The potential role of gut microbiota in pancreatic disease: A systematic review.

Memba R, Duggan SN, Ni Chonchubhair HM, Griffin OM, Bashir Y, O'Connor DB, Murphy A, McMahon J, Volcov Y, Ryan BM, Conlon KC.

Pancreatology. 2017 Nov - Dec;17(6):867-874. doi: 10.1016/j.pan.2017.09.002. Epub 2017 Sep 6. Review.

PMID:
28935288
20.

IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities.

Dubois S, Conlon KC, Müller JR, Hsu-Albert J, Beltran N, Bryant BR, Waldmann TA.

Cancer Immunol Res. 2017 Oct;5(10):929-938. doi: 10.1158/2326-6066.CIR-17-0279. Epub 2017 Aug 25.

21.

Step by step guide to do a systematic review and meta-analysis for medical professionals.

Bashir Y, Conlon KC.

Ir J Med Sci. 2018 May;187(2):447-452. doi: 10.1007/s11845-017-1663-3. Epub 2017 Jul 22. Review.

PMID:
28735501
22.

Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?

Healy GM, Redmond CE, Murphy S, Fleming H, Haughey A, Kavanagh R, Swan N, Conlon KC, Malone DE, Ryan ER.

Abdom Radiol (NY). 2018 Mar;43(3):620-628. doi: 10.1007/s00261-017-1254-9.

PMID:
28695235
23.

The predictive value of C-reactive protein (CRP) in acute pancreatitis - is interval change in CRP an additional indicator of severity?

Stirling AD, Moran NR, Kelly ME, Ridgway PF, Conlon KC.

HPB (Oxford). 2017 Oct;19(10):874-880. doi: 10.1016/j.hpb.2017.06.001. Epub 2017 Jul 8.

24.

Assessment of Vulnerability to Coccidioidomycosis in Arizona and California.

Shriber J, Conlon KC, Benedict K, McCotter OZ, Bell JE.

Int J Environ Res Public Health. 2017 Jun 23;14(7). pii: E680. doi: 10.3390/ijerph14070680.

25.

Standardizing terminology for minimally invasive pancreatic resection.

Montagnini AL, Røsok BI, Asbun HJ, Barkun J, Besselink MG, Boggi U, Conlon KC, Fingerhut A, Han HS, Hansen PD, Hogg ME, Kendrick ML, Palanivelu C, Shrikhande SV, Wakabayashi G, Zeh H, Vollmer CM, Kooby DA.

HPB (Oxford). 2017 Mar;19(3):182-189. doi: 10.1016/j.hpb.2017.01.006. Review.

26.

Minimally invasive pancreatic resections: cost and value perspectives.

Conlon KC, de Rooij T, van Hilst J, Abu Hidal M, Fleshman J, Talamonti M, Vanounou T, Garfinkle R, Velanovich V, Kooby D, Vollmer CM; Minimally Invasive Pancreatic Resection Organizing Committee.

HPB (Oxford). 2017 Mar;19(3):225-233. doi: 10.1016/j.hpb.2017.01.019. Epub 2017 Mar 6.

27.

Worldwide survey on opinions and use of minimally invasive pancreatic resection.

van Hilst J, de Rooij T, Abu Hilal M, Asbun HJ, Barkun J, Boggi U, Busch OR, Conlon KC, Dijkgraaf MG, Han HS, Hansen PD, Kendrick ML, Montagnini AL, Palanivelu C, Røsok BI, Shrikhande SV, Wakabayashi G, Zeh HJ, Vollmer CM, Kooby DA, Besselink MG.

HPB (Oxford). 2017 Mar;19(3):190-204. doi: 10.1016/j.hpb.2017.01.011. Epub 2017 Feb 17.

28.

Proceedings of the first international state-of-the-art conference on minimally-invasive pancreatic resection (MIPR).

Vollmer CM, Asbun HJ, Barkun J, Besselink MG, Boggi U, Conlon KC, Han HS, Hansen PD, Kendrick ML, Montagnini AL, Palanivelu C, Røsok BI, Shrikhande SV, Wakabayashi G, Zeh HJ, Kooby DA.

HPB (Oxford). 2017 Mar;19(3):171-177. doi: 10.1016/j.hpb.2017.01.015. Epub 2017 Feb 8.

29.

Gastrointestinal Stromal Tumors in Younger Patients: A Start but More to Do!

O'Connor DB, Conlon KC.

JAMA Surg. 2017 May 1;152(5):451. doi: 10.1001/jamasurg.2016.5048. No abstract available.

PMID:
28114503
30.

Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS).

Shrikhande SV, Sivasanker M, Vollmer CM, Friess H, Besselink MG, Fingerhut A, Yeo CJ, Fernandez-delCastillo C, Dervenis C, Halloran C, Gouma DJ, Radenkovic D, Asbun HJ, Neoptolemos JP, Izbicki JR, Lillemoe KD, Conlon KC, Fernandez-Cruz L, Montorsi M, Bockhorn M, Adham M, Charnley R, Carter R, Hackert T, Hartwig W, Miao Y, Sarr M, Bassi C, Büchler MW; International Study Group of Pancreatic Surgery (ISGPS).

Surgery. 2017 May;161(5):1221-1234. doi: 10.1016/j.surg.2016.11.021. Epub 2016 Dec 24. Review.

PMID:
28027816
31.

The role of endoscopic intervention in the management of inflammatory pancreatic fluid collections.

Parihar V, Ridgway PF, Conlon KC, Huggett M, Ryan BM.

Eur J Gastroenterol Hepatol. 2017 Apr;29(4):371-379. doi: 10.1097/MEG.0000000000000818. Review.

PMID:
28009718
32.

Hospital discharges and patient activity associated with chronic pancreatitis in Ireland 2009-2013.

Ní Chonchubhair HM, Bashir Y, McNaughton D, Barry JM, Duggan SN, Conlon KC.

Pancreatology. 2017 Jan - Feb;17(1):56-62. doi: 10.1016/j.pan.2016.11.006. Epub 2016 Nov 25.

PMID:
27916415
33.

Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery.

Besselink MG, van Rijssen LB, Bassi C, Dervenis C, Montorsi M, Adham M, Asbun HJ, Bockhorn M, Strobel O, Büchler MW, Busch OR, Charnley RM, Conlon KC, Fernández-Cruz L, Fingerhut A, Friess H, Izbicki JR, Lillemoe KD, Neoptolemos JP, Sarr MG, Shrikhande SV, Sitarz R, Vollmer CM, Yeo CJ, Hartwig W, Wolfgang CL, Gouma DJ; International Study Group on Pancreatic Surgery.

Surgery. 2017 Feb;161(2):365-372. doi: 10.1016/j.surg.2016.06.058. Epub 2016 Sep 28. Review.

PMID:
27692778
34.

Working with Climate Projections to Estimate Disease Burden: Perspectives from Public Health.

Conlon KC, Kintziger KW, Jagger M, Stefanova L, Uejio CK, Konrad C.

Int J Environ Res Public Health. 2016 Aug 9;13(8). pii: E804. doi: 10.3390/ijerph13080804.

35.

The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.

Duggan SN, Ewald N, Kelleher L, Griffin O, Gibney J, Conlon KC.

Eur J Clin Nutr. 2017 Jan;71(1):3-8. doi: 10.1038/ejcn.2016.127. Epub 2016 Jul 13. Review.

PMID:
27406162
36.

Spontaneous resolution of avascular necrosis of femoral heads following cure of Cushing's syndrome.

Pazderska A, Crowther S, Govender P, Conlon KC, Sherlock M, Gibney J.

Endocrinol Diabetes Metab Case Rep. 2016;2016:160015. doi: 10.1530/EDM-16-0015. Epub 2016 May 1.

37.

Chronic pancreatitis: A diagnostic dilemma.

Duggan SN, Ní Chonchubhair HM, Lawal O, O'Connor DB, Conlon KC.

World J Gastroenterol. 2016 Feb 21;22(7):2304-13. doi: 10.3748/wjg.v22.i7.2304. Review.

38.

90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Janik JE, Morris JC, O'Mahony D, Pittaluga S, Jaffe ES, Redon CE, Bonner WM, Brechbiel MW, Paik CH, Whatley M, Chen C, Lee JH, Fleisher TA, Brown M, White JD, Stewart DM, Fioravanti S, Lee CC, Goldman CK, Bryant BR, Junghans RP, Carrasquillo JA, Worthy T, Corcoran E, Conlon KC, Waldmann TA.

Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13045-50. doi: 10.1073/pnas.1516107112. Epub 2015 Oct 5.

39.

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.

Kreitman RJ, Stetler-Stevenson M, Jaffe ES, Conlon KC, Steinberg SM, Wilson W, Waldmann TA, Pastan I.

Clin Cancer Res. 2016 Jan 15;22(2):310-8. doi: 10.1158/1078-0432.CCR-15-1412. Epub 2015 Sep 8.

40.

Postoperative exercise training is associated with reduced respiratory infection rates and early discharge: A case-control study.

Bhatt NR, Sheridan G, Connolly M, Kelly S, Gillis A, Conlon KC, Lane S, Shanahan E, Ridgway PF.

Surgeon. 2017 Jun;15(3):139-146. doi: 10.1016/j.surge.2015.07.003. Epub 2015 Aug 15.

PMID:
26283303
41.

The Impact of Social Work Intervention in Alcohol-Induced Pancreatitis in Ireland: a Single-Center Experience.

Beagon C, Bhatt NR, Donnelly SM, Egan M, McKay AP, Mehigan B, Conlon KC, Ridgway PF.

Alcohol Alcohol. 2015 Jul;50(4):438-43. doi: 10.1093/alcalc/agv040. Epub 2015 May 1.

PMID:
25935157
42.

Evaluation of a "Subintern" Role: Action Over Observation For Final-Year Medical Students in Surgery.

Morris MC, Hennessy M, Conlon KC, Ridgway PF.

J Surg Educ. 2015 Sep-Oct;72(5):862-7. doi: 10.1016/j.jsurg.2015.03.003. Epub 2015 Apr 23.

PMID:
25921190
43.

Pancreaticopleural fistula as a presentation of a pancreatic neoplasm. A report of a case and review of the literature.

Redmond CE, McEvoy SH, Cullen A, Skehan SJ, Conlon KC.

JOP. 2015 Jan 31;16(1):95-6. doi: 10.6092/1590-8577/2895. No abstract available.

44.

An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.

Duggan SN, Purcell C, Kilbane M, O'Keane M, McKenna M, Gaffney P, Ridgway PF, Boran G, Conlon KC.

Am J Gastroenterol. 2015 Feb;110(2):336-45. doi: 10.1038/ajg.2014.430. Epub 2015 Jan 27.

PMID:
25623657
45.

Vulnerability to extreme heat by socio-demographic characteristics and area green space among the elderly in Michigan, 1990-2007.

Gronlund CJ, Berrocal VJ, White-Newsome JL, Conlon KC, O'Neill MS.

Environ Res. 2015 Jan;136:449-61. doi: 10.1016/j.envres.2014.08.042. Epub 2014 Nov 25.

46.

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Conlon KC, Lugli E, Welles HC, Rosenberg SA, Fojo AT, Morris JC, Fleisher TA, Dubois SP, Perera LP, Stewart DM, Goldman CK, Bryant BR, Decker JM, Chen J, Worthy TA, Figg WD Sr, Peer CJ, Sneller MC, Lane HC, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA.

J Clin Oncol. 2015 Jan 1;33(1):74-82. doi: 10.1200/JCO.2014.57.3329. Epub 2014 Nov 17.

47.

Standardization of management in acute pediatric pancreatitis: a tertiary centre perspective.

Quinlan CS, McDermott R, Moran N, Sweeney B, Lakshmanadass G, Conlon KC, Ridgway PF.

Scand J Gastroenterol. 2014 Dec;49(12):1503-4. doi: 10.3109/00365521.2014.958525. Epub 2014 Sep 16. No abstract available.

PMID:
25226062
48.

Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.

Yu P, Petrus MN, Ju W, Zhang M, Conlon KC, Nakagawa M, Maeda M, Bamford RN, Waldmann TA.

Leukemia. 2015 Mar;29(3):556-66. doi: 10.1038/leu.2014.241. Epub 2014 Aug 14.

49.

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).

Tol JA, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, Andrén-Sandberg A, Asbun HJ, Bockhorn M, Büchler MW, Conlon KC, Fernández-Cruz L, Fingerhut A, Friess H, Hartwig W, Izbicki JR, Lillemoe KD, Milicevic MN, Neoptolemos JP, Shrikhande SV, Vollmer CM, Yeo CJ, Charnley RM; International Study Group on Pancreatic Surgery.

Surgery. 2014 Sep;156(3):591-600. doi: 10.1016/j.surg.2014.06.016. Epub 2014 Jul 22.

PMID:
25061003
50.

Pancreatic metastasectomy: experience of the Irish National Surgical Centre for Pancreatic Cancer.

Redmond CE, Adler H, Heneghan HM, Kelly R, Swan N, Cantwell CP, Maguire D, Traynor O, Hoti E, Geoghegan JG, Conlon KC.

Ir J Med Sci. 2014 Dec;183(4):677-80. doi: 10.1007/s11845-014-1175-3. Epub 2014 Jul 24.

PMID:
25056586

Supplemental Content

Loading ...
Support Center